RightFit
RecruitingPhase not listed

Breast Cancer Survivorship Biorepository

A Comprehensive Breast Cancer Survivorship Biorepository

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Female only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Blood draws, Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use."
  • "To create an annotated biorepository with prospectively collected blood samples from breast cancer survivors."
  • "OUTLINE: Patients complete surveys, undergo collection of blood samples, and review of medical records on study."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study collects blood samples, health records, and information shared by women who have finished treatment for stage I–III breast cancer. These will be stored for future research on how personal traits, molecules, and genes relate to cancer outcomes.

This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Women age 18 or older, of any racial or ethnic group.
  • Diagnosed within the past 7 years with stage I–III invasive breast cancer, which has grown into nearby breast tissue.
  • Finished active breast cancer treatment, including surgery, chemotherapy, HER2-targeted medicine, and radiation.
  • Past participation in other clinical trials is allowed.

Who can't join

  • Currently taking part in a clinical trial that tests a treatment or other health intervention.
  • Stage IV cancer, which has spread to distant parts of the body.
  • Cancer has come back before, unless it came back after ductal carcinoma in situ (DCIS), a cancer limited to the breast milk ducts.
  • Unable to give informed consent, which means understanding the study and agreeing to join.
  • Unable to speak any of these languages: English, Spanish, Chinese, or Korean.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Women of all racial and ethnic groups 18 years of age or older * Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years * Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation) * Prior participation on clinical trials is allowed Exclusion Criteria: * Current receipt of interventional clinical trial participation * Stage IV (metastatic) cancer * Prior history of recurrence (except recurrence following ductal carcinoma in situ) * Inability to give informed consent * Unable to speak English, Spanish, Chinese, or Korean

Study sites (1)

CA